A Comparative Study: Immunohistochemical Detection of Cytosolic Thymidine Kinase and Proliferating Cell Nuclear Antigen in Breast Cancer

REFERENCES

• Sullivan R.P., Mortimer G., Muircheartaigh I.O. Cell Proliferation in Breast Tumor: Analysis of Histological Parameters Ki67 and PCNA Expression. Ir. J. Med. Sci. 1993; 162: 343–347
   PubMed Web of Science ®Google Scholar
• Schwartz G.F., Schwarting R., Rabindranauth P., Finkel G.C. Clinical Application of Serum and Tissue Markers in Malignant Disease: Breast Cancer as the Paradigm. Clin. Chem. 1993; 39: 2401–2412
   Google Scholar
• Keshgegian A.A., Cnaan A. Proliferation Markers in Breast Carcinoma. Mitotic Figure Count, S-Phase Fraction, Proliferating Cell Nuclear Antigen, Ki-67 and MIB-1. Am. J. Clin. Pathol. 1995; 104: 42–49
   PubMed Web of Science ®Google Scholar
• Haerslev T., Jacobsen G.K., Zedeler K. Correlation of Growth Fraction by Ki-67 and Proliferating Cell Nuclear Antigen (PCNA) Immunohistochemistry with Histopathological Parameters and Prognosis in Primary Breast Carcinomas. Breast Cancer Res. Treat. 1996; 37: 101–113
   PubMed Web of Science ®Google Scholar
• Landberg G., Roos G. The Cell Cycle in Breast Cancer. APMIS 1997; 105: 575–589
   PubMed Web of Science ®Google Scholar
• van Dierendonck J.H., Wijsman J.H., Keijzer R., vande Velde C.J., Cornelisse C.J. Cell-Cycle-Related Staining Patterns of Anti-proliferating Cell Nuclear Antigen Monoclonal Antibodies. Comparison with BrdUrd Labeling and Ki-67 Staining. Am. J. Pathol. 1991; 138: 1165–1172
   PubMed Web of Science ®Google Scholar
• Uporov A.V., Tsyrlina E.V., Pozharisskii K.M. Immunohistochemical Study of the Proliferation of Breast Cancer Cells Based on the Expression of Proliferating Cell Nuclear Antigen. Vopr. Onkol. 1998; 44: 49–53
   PubMedGoogle Scholar
• Agarwal S., Jain R., Rusia U., Gupta R.L. Proliferating Cell Nuclear Antigen Immunostaining in Breast Carcinoma and Its Relationship to Clinical and Pathological Variables. Indian J. Pathol. Microbiol. 1997; 40: 11–16
   PubMedGoogle Scholar
• Moriki T., Takahashi T., Kataoka H., Hiroi M., Yamane T., Hara H. Proliferation Marker MIB-1 Correlates Well with Proliferative Activity Evaluated BrdU in Breast Cancer: An Immunohistochemical Study Including Correlation with PCNA, P53, c-erbB-2 and Estrogen Receptor Status. Pathol. Int. 1996; 46: 953–961
   PubMed Web of Science ®Google Scholar
• Chu J.S., Huang C.S., Chang K.J. Proliferating Cell Nuclear Antigen (PCNA) Immunolabeling as a Prognostic Factor in Invasive Ductal Carcinoma of the Breast in Taiwan. Cancer Lett. 1998; 25: 145–152
   Google Scholar
• Niewiadomska H., Jeziorski A., Olborski B. The Expression of the Proliferating Antigen Ki67, PCNA and Products of Suppressor Gene p53 in Primary Invasive Ductal Breast Carcinoma. J. Exp. Clin. Cancer Res. 1998; 17: 503–510
   PubMed Web of Science ®Google Scholar
• Kid S., Leung W.C., Kaplan A. Distinctive Molecular Form of Thymidine Kinase in Mitochondria of Normal and Bromodeoxyuridine Resistant HeLa Cells. Eur. J. Biochem. 1973; 39: 43–48
   PubMedGoogle Scholar
• Kid S. Thymidine Kinase. Microbiol. Sci. 1985; 2: 369–375
   PubMedGoogle Scholar
• Sherley J.L., Kelly T.J. Regulation of Human Thymidine Kinase During the Cell Cycle. J. Biol. Chem. 1988; 263: 8350–8358
   PubMed Web of Science ®Google Scholar
• He Q., Skog S., Tribukait B. Cell Cycle Related Studies on Thymidine Kinase and Its Isoenzymes in Ehrlich Ascites Tumors. Cell Prolif. 1991; 24: 3–14
   PubMed Web of Science ®Google Scholar
• Hengstschläger M., Knöfler M., Müllner E.W., Ogris E., Wintersberger E., Wawra E. Different Regulation of Thymidine Kinase During the Cell Cycle of Normal Versus DNA Tumor Virus-Transformed Cells. J. Biol. Chem. 1994; 19: 13836–13842
   Google Scholar
• He Q., Wang N., Skog S., Ericsson S., Tribukait B. Characterization of a Peptide Antibody Against a C-Terminal Part of Human and Mouse Cytosolic Thymidine Kinase, Which Is Marker for Cell Proliferation. Eur. J. Cell Biol. 1996; 70: 117–124
   PubMed Web of Science ®Google Scholar
• Romain S., Spyratos F., Descotes F., Daver A., Rastaing-Puissant B., Bougnoux P., Colonna M., Bolla M., Matin P.-M. Prognostic of DNA-Synthesizing Enzyme Activities (Thymidine Kinase and Thymidylate Synthase) in 908 T1-T2, N0-N1, M0 Breast Cancers: A Retrospective Multicenter Study. Int. J. Cancer 2000; 87: 860–868
   PubMed Web of Science ®Google Scholar
• Wang N., He Q., Skog S., Ericsson S., Tribukait B. Investigation on Cell Proliferation with a New Antibody Against Thymidine Kinase 1. Anal. Cell. Pathol. 2001; 23: 11–19
   PubMed Web of Science ®Google Scholar
• Wang N., Tribukait B. Proliferation Activity in Carcinoma and Intrapithetial Neoplasia of the Prostate as Assessed by Expression of Thymidine Kinase 1 and Ki-67, and by DNA Cytometry. Qualitative Cellular Methods in the Evaluation of Prostate Cancer, N. Wang, Täby-Tryck AB, Stockholm 2000, Paper VII, pp. 1–17
   Google Scholar
• Frierson H.F., Jr., Wolber R.A., Berean K.W., Franquemont D.W., Gaffey M.J., Boyd J.C., Wibur D.C. Interobserver Reproducibility of the Nottingham Modification of the Bloom and Richardson Histologic Grading Scheme for Infiltrating Ductal Carcinoma. Am. J. Clin. Pathol. 1995; 103: 195–198
   PubMed Web of Science ®Google Scholar
• Spiessl B., Beahrs O.H., Hermanek P. UICC International Union Against Cancer. TNM Atlas: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. Springer-Verlag, Berlin 1989
   Google Scholar
• Bravo R. Synthesis of the Nuclear Protein Cyclin (PCNA) and Its Relationship with DNA Replication. Exp. Cell Res. 1986; 163: 287–293
   PubMed Web of Science ®Google Scholar
• Bronzert D.A., Monaco M.E., Pinkus L., Aitken S., Lippman M.E. Purification and Properties of Estrogen-Responsive Cytolasmic Thymidine Kinase from Human Breast Cancer. Cancer Res. 1981; 41: 604–610
   PubMed Web of Science ®Google Scholar
• Romain S., Christensen I.J., Chinot O., Balslev I., Rose C., Martin P.-M., Thorpe S.M. Prognostic Value of Cytosolic Thymidine Kinase Activity as Marker of Proliferation in Breast Cancer. Int. J. Cancer 1995; 61: 7–12
   PubMed Web of Science ®Google Scholar
• Spyratos F., Martin P.M., Hacéne K., Romain S., Andrieu C., Ferrero-Paüs M., Deytieux S., Doussal V.L., Tubiana-Hulin M., Brunet M. Multiparametric Prognostic Evaluation of Biological Factors in Primary Breast Cancer. J. Natl Cancer Inst. 1992; 84: 1266–1272
   PubMed Web of Science ®Google Scholar
• Romain S., Martin P.M., Klijin J.G., van Putten W.L., Look M.P., Guirou O., Foekens J.A. DNA-Synthesis Enzyme Activity: A Biological Tool Useful for Predicting Anti-metabolic Drug Sensitivity in Breast Cancer?. Int. J. Cancer 1997; 74: 156–161
   PubMed Web of Science ®Google Scholar
• O'Neill K.L., Hoper M., Odling-Smee G.W. Can Thymidine Kinase Levels in Breast Tumors Predict Disease Recurrence?. J. Natl Cancer Inst. 1992; 84: 1925–1928
   Google Scholar
• He Q., Zou L., Zhang P.A., Liu J.T., Skog S., Fonander T. The Clinical Significance of Thymidine Kinase 1 Measurement in Serum of Breast Cancer Patients Using Anti-TK1 Antibody. Int. Biol. Markers 2000; 15: 139–144
   PubMed Web of Science ®Google Scholar
• Wu J.P., Mao Y.R., He L.X., Wang N., Wu C.J., He Q., Skog S. Comparison Study on the Expression of Cytosolic Thymidine Kinase and Proliferating Cell Nuclear Antigen in Colorectal Carcinoma. Anticancer Res. 2000; 6: 4867
   Google Scholar
• Simpson J.F., Page D.L., Steeg P.S. Overexpression of Cyclin D mRNA Distinguishes Invasive and In Situ Breast Carcinomas from Non-Malignant Lesions. Nat. Med. 1995; 1: 1257–1260
   PubMed Web of Science ®Google Scholar
• Zhou Q., Wulfkuhle J., Ouatas T., et al. Cyclin D1 Overexpression in a Model of Human Breast Premalignancy: Preferential Stimulation of Anchorage-Independent But Not Anchorage-Dependent Growth Is Associated with Increased cdk2 Activity. Breast Cancer Res. Treat. 2000; 59: 27–39
   PubMed Web of Science ®Google Scholar